About Index Trending news
Analyze
Pricing
BeiGene

BeiGene

BeiGene

BeiGene is a Chinese life sciences biotechnology company based in Beijing that is focused on discovering and developing innovative oncology drugs that will address unmet medical needs in cancers that are prevalent in China and the AsiaPacific region..

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$185,000,000
Employees

Team size

50+
Locations
HQ
Headquarters
Xconomy

Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal

Health
$185,000,000 Post-IPO equity
Seeking Alpha

Week In Review: Beijing's BeiGene Raises $185 Million For Clinical Trial Program